EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Acetylation of Histone H3 in Cancer Progression and Prognosis

Paulina Miziak, Marzena Baran, Lidia Borkiewicz, Tomasz Trombik iD, Andrzej Stepulak iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252010982 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paulina Miziak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Street, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Histones, Neoplasms, Protein Processing, Post-Translational, Disease Progression. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University in Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a multifactorial disease resulting from both genetic factors and epigenetic changes. Histone acetylation, a post-translational modification, which alters chromatin architecture and regulates gene expression is associated with cancer initiation, development and progression. Aberrations in global histone acetylation levels are observed in various cancer cells and are also associated with patients’ tumor aggressiveness. Therefore, histone acetylation may have prognostic utility and serve as a potential biomarker of cancer progression and patients’ prognosis. The reversible modification of histones by an acetyl group is versatile. One particular histone can be acetylated on different lysine residues, subsequently resulting in different biological outcomes. Here, we discuss recent findings on the acetylation of the highly conserved histone protein H3 in the context of cancer biology. Specifically, we review the acetylation of particular H3 residues in various cancer types. We further highlight the significance of H3 acetylation levels as a potential cancer biomarker with prognostic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesNeoplasmsProtein Processing, Post-TranslationalDisease ProgressionHumansAcetylationPrognosisBiomarkers, TumorEpigenesis, GeneticAnimals

Stichwörter der Autor:innen

biomarkercancercancer prognosiscancer progressionhistone H3histone acetylation

Substanzen

HistonesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Street, 20-093 Lublin, Poland.

ORCID-Profile: Tomasz Trombik, Andrzej Stepulak

Förderung

  • Medical University in Lublin

Zitieren

APA

Miziak, P., Baran, M., Borkiewicz, L., Trombik, T., & Stepulak, A. (2024). Acetylation of Histone H3 in Cancer Progression and Prognosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010982

Vancouver

Miziak P, Baran M, Borkiewicz L, Trombik T, Stepulak A. Acetylation of Histone H3 in Cancer Progression and Prognosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010982

BibTeX
@article{Miziak2024,
  author = {Miziak, Paulina and Baran, Marzena and Borkiewicz, Lidia and Trombik, Tomasz and Stepulak, Andrzej},
  title = {Acetylation of Histone H3 in Cancer Progression and Prognosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252010982}
}
Kostenlos starten →